Clinical Trials
20 trialsNCT04534205 2026-05-22
AHEAD-MERIT
BioNTech SE
Phase 2/3 Recruiting
NCT06788990 2026-05-14
FORTIFI-HN01
Bicara Therapeutics
Phase 2/3 Recruiting
NCT01810913 2026-05-13
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2/3 Recruiting
NCT07444723 2026-05-12
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
National Institutes of Health Clinical Center (CC)
Phase 2/3 Recruiting
NCT07573956 2026-05-07
Radiotherapy
All India Institute of Medical Sciences
Phase 2/3 Recruiting
NCT07528495 2026-05-06
Eliminate
All India Institute of Medical Sciences
Phase 2/3 Recruiting
NCT04333537 2026-05-04
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
NRG Oncology
Phase 2/3 Recruiting
NCT05893888 2026-04-23
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
Privo Technologies
Phase 2/3 Recruiting
NCT07353671 2026-03-25
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
West China Hospital
Phase 2/3 Recruiting
NCT06030440 2026-03-13
DIREKHT2
University of Erlangen-Nürnberg Medical School
Phase 2/3 Recruiting
NCT07310758 2025-12-30
Contrast-enhanced Ultrasound for Sentinel Node Detection
The Netherlands Cancer Institute
Phase 2/3 Recruiting
NCT06851663 2025-12-08
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
Phase 2/3 Recruiting
NCT05786716 2025-12-02
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05891769 2025-09-10
18FCH
Stanford University
Phase 2/3 Recruiting
NCT05429099 2025-07-24
ViPMR
University of British Columbia
Phase 2/3 Recruiting
NCT03952065 2024-06-26
IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT03755739 2024-06-25
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT06241599 2024-02-05
A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 2/3 Recruiting
NCT05125055 2023-11-22
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting